Division of Evidence Based Medicine (dEBM), Klinik für Dermatologie, Venerologie und Allergologie, Charité - Universitätsmedizin Berlin, Charité Campus Mitte, Charitéplatz, 1, 10117, Berlin, Germany.
Br J Dermatol. 2013 Sep;169(3):502-18. doi: 10.1111/bjd.12420.
Knowledge about the development of untreated actinic keratosis (AK) and risk of progression into squamous cell carcinoma (SCC) is important. Therefore, we set out to synthesize primary data on the natural history of AK. We carried out a systematic literature search (Medline, Medline in Process, Embase, Cochrane) of studies on the natural course of AK, regarding (i) progression and regression rates per lesion-year, (ii) changes in total lesion counts over time, and (iii) spontaneous field regression and recurrence rates, taking into account studies on participants without immunosuppression and history of skin cancer, immunosuppressed patients and participants with a history of skin cancer and sunscreen use. Twenty-four eligible studies were identified providing data on at least one of the outcomes. Progression rates of AK to SCC ranged from 0% to 0·075% per lesion-year, with a risk of up to 0·53% per lesion in patients with prior history of nonmelanoma skin cancer. Rates of regression of single lesions ranged between 15% and 63% after 1 year. The data available on recurrence rates of single lesions 1 year after regression indicate a recurrence rate of 15-53%. Data on the relative change of total AK count over time are heterogeneous, and range from -53% to +99·1%. Spontaneous complete field regression rates range from 0% to 21%, with recurrences in 57%. In general, the available data are limited. Important methodological limitations apply. Currently, no reliable estimates concerning the frequency of AK developing into invasive carcinoma can be given, and further studies are needed.
关于未经治疗的光化性角化病 (AK) 的发展以及进展为鳞状细胞癌 (SCC) 的风险的知识很重要。因此,我们着手综合 AK 的自然病史的原始数据。我们对 AK 自然病程的研究进行了系统的文献检索 (Medline、Medline in Process、Embase、Cochrane),研究了 (i) 每病变年的进展和消退率、(ii) 随时间推移的总病变计数的变化,以及 (iii) 自发的野外消退和复发率,同时考虑了无免疫抑制和皮肤癌病史的参与者、免疫抑制患者以及有皮肤癌和防晒霜使用史的参与者的研究。确定了 24 项符合条件的研究,这些研究提供了至少一种结果的数据。AK 向 SCC 的进展率为每病变年 0%至 0·075%,有皮肤癌病史的患者每病变的风险高达 0·53%。单一病变的消退率在 1 年后在 15%至 63%之间。在 1 年消退后关于单个病变复发率的数据表明复发率为 15-53%。关于总 AK 计数随时间相对变化的数据存在异质性,范围从 -53%至 +99·1%。自发完全野外消退率从 0%至 21%不等,复发率为 57%。总的来说,目前可用的数据是有限的。重要的方法学局限性适用。目前,无法给出 AK 发展为浸润性癌的频率的可靠估计,需要进一步的研究。